High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas
Authors
Keywords
Mixed glioma, Outcome, Prognosis, Progression-free survival, Low-grade gliomas, Anaplastic gliomas
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 117, Issue 1, Pages 183-189
Publisher
Springer Nature
Online
2014-02-11
DOI
10.1007/s11060-014-1376-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH1 Mutations in Diffusely Infiltrating Astrocytomas
- (2012) Balaram Thota et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas
- (2012) Hideo Arai et al. Brain Tumor Pathology
- Association of Stem Cell-Related Markers and Survival in Astrocytic Gliomas
- (2011) Feng Wan et al. BIOMARKERS
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
- (2010) Philippe Metellus et al. ACTA NEUROPATHOLOGICA
- Detection of IDH1 and IDH2 Mutations by Fluorescence Melting Curve Analysis as a Diagnostic Tool for Brain Biopsies
- (2010) Craig Horbinski et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Nestin Is Essential for Zebrafish Brain and Eye Development through Control of Progenitor Cell Apoptosis
- (2010) Hua-Ling Chen et al. PLoS One
- Nestin Is Required for the Proper Self-Renewal of Neural Stem Cells
- (2010) Donghyun Park et al. STEM CELLS
- Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research
- (2009) S. Madhavan et al. MOLECULAR CANCER RESEARCH
- IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide
- (2009) H. J. Dubbink et al. NEUROLOGY
- Issues of Diagnostic Review in Brain Tumor Studies: From the Brain Tumor Epidemiology Consortium
- (2008) F. G. Davis et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group
- (2008) Prakash Chinnaiyan et al. Radiation Oncology
- Nestin small interfering RNA (siRNA) reduces cell growth in cultured astrocytoma cells
- (2007) Li-Chun Wei et al. BRAIN RESEARCH
- Nestin expression in different tumours and its relevance to malignant grade
- (2007) X H Yang et al. JOURNAL OF CLINICAL PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started